Use of erythromycin for the treatment of severe chronic constipation in children

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 10, 2003, Pages 1391-1396

  Bellomo Brandao M A ^a   Collares, E F ^a   da Costa Pinto, Eliz A L ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Children; Constipation; Erythromycin; Gastrointestinal motility; Prokinetics

Indexed keywords

ERYTHROMYCIN ESTOLATE; LACTULOSE; LAXATIVE; MAGNESIUM HYDROXIDE; PLACEBO; PROKINETIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; FECES IMPACTION; FOLLOW UP; GASTROENTEROLOGY; HUMAN; MEDICAL DOCUMENTATION; OUTPATIENT DEPARTMENT; PEDIATRIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 0142241433     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003001000016     Document Type: Article

References (20)

1. Zaslavsky C, da Silveira TR & Maguilnik I (1998). Total and segmental colonic transit time with radio-opaque markers in adolescents with functional constipation. Journal of Pediatric Gastroenterology and Nutrition, 27: 138-142.
2. Loening-Baucke V (1989). Factors determining outcome in children with chronic constipation and faecal soiling. Gut, 30: 999-1006.
3. Nurko S, Garcia-Aranda JA, Worona LB & Zlochisty O (2000). Cisapride for the treatment of constipation in children: A double-blind study. Journal of Pediatrics, 136: 35-40.
4. + channel by the gastrointestinal prokinetic agent cisapride. American Journal of Physiology, 273: H2534-H2538.
5. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S & Zinsmeister AR (2001). Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology, 120: 354-360.
6. Coolie B, Tack J, Peeters T & Janssens J (1998). Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut, 43: 395-400.
7. Curry JI, Lander TD & Stringer MD (2001). Review article: erythromycin as a prokinetic agent in infants and children. Alimentary Pharmacology and Therapeutics, 15: 595-603.
8. Costalos C, Gounaris A, Varhalama E, Kokori F, Alexiou N & Kolovou E (2002). Erythromycin as a prokinetic agent in preterm infants. Journal of Pediatric Gastroenterology and Nutrition, 34: 23-25.
9. Di Lorenzo C, Flores AF, Tomomasa T & Hyman PE (1994). Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms. Digestive Diseases and Sciences, 39: 1399-1404.
10. Jadcherla SR & Berseth CL (2002). Effect of erythromycin on gastro-duodenal contractile activity in developing neonates. Journal of Pediatric Gastroenterology and Nutrition, 34: 16-22.
11. Stenson BJ, Middlemist L & Lyon AJ (1998). Influence of erythromycin on establishment of feeding in preterm infants: observations from a iandomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition, 79: F212-F214.
12. Patole SK, Almonte R, Kadalraja R, Tuladhar R, Muller R & Whitehall JS (2000). Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? International Journal of Clinical Practice, 54: 504-508.
13. Knowles CH, Eccersley AJ, Scott SM, Walker SM, Reeves B & Lunnis PJ (2000). Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system. Diseases of the Colon and Rectum, 41: 1419-1426.
14. Otterson MF & Sarna SK (1990). Gastrointestinal motor effects of erythromycin. American Journal of Physiology, 249: G355-G363.
15. Brandriss MW, Richardson WS & Barold SS (1994). Erythromycin-induced OT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clinical Infectious Diseases, 18: 995-998.
16. Westphal JF, Vetter D & Brogard JM (1994). Hepatic side effects of antibiotics. Journal of Antimicrobial Chemotherapy, 33: 387-401.
17. Landry C, Vidon N, Sogni P, Nepveux P, Chaumeil JC, Chauvin JP & Couturier D (1995). Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers. European Journal of Gastroenterology and Hepatology, 7: 797-802.
18. Feighner SD, Tan CP, McKee KK et al. (1999). Receptor for motilin identified in the human gastrointestinal system. Science, 284: 2184-2188.
19. Sharma SS, Bhargava N & Mathur SC (1995). Effect of oral erythromycin on colonic transit in patients with idiopathic constipation. A pilot study. Digestive Diseases and Sciences, 40: 2446-2449.
20. Loening-Baucke VA (1987). Factors responsible for persistence of childhood constipation. Journal of Pediatric Gastroenterology and Nutrition, 6: 15-22.